Steroid receptors and cell cycle in normal mammary epithelium

被引:123
作者
Anderson, E [1 ]
Clarke, RB [1 ]
机构
[1] Christie Hosp NHS Trust, Dept Clin Res, Manchester M20 4BX, Lancs, England
关键词
mammary epithelium; estrogen; progesterone; estrogen receptor; progesterone receptor; cell cycle;
D O I
10.1023/B:JOMG.0000023584.01750.16
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The ovarian steroids estrogen and progesterone (E-2 and P) are essential for normal mammary gland growth and development; however, the mechanisms by which they influence the proliferative activity of the mammary epithelium remain unclear. Mammary epithelial cells cells expressing the receptors for E-2 and P ( ER and PR respectively) are separate from, although often adjacent to, those capable of proliferating, implying that the ovarian steroids act indirectly via paracrine or juxtacrine growth factors to stimulate entry into the cell cycle. A large number of candidate factors have been identified in a variety of different experimental systems, and it appears that transforming growth factor beta may play a role in preventing proliferation of steroid receptor-containing cells. Dysregulation of the strict inverse relationship between ERalpha expression and proliferation is detectable in premalignant human breast lesions, indicating that it might be essential to the tumorigenic process. Challenges for the future include determining which of the candidates identified as being mediators of the effects of E-2 are physiologically and clinically relevant as well as finding out how ERalpha-containing cells become proliferative during tumorigenesis. Answering these questions could greatly increase our understanding of the factors controlling mammary gland development and the processes leading to cancer formation.
引用
收藏
页码:3 / 13
页数:11
相关论文
共 70 条
[1]   Endocrine-responsive breast cancer and strategies for combating resistance [J].
Ali, S ;
Coombes, RC .
NATURE REVIEWS CANCER, 2002, 2 (02) :101-+
[2]   Histological and biological evolution of human premalignant breast disease [J].
Allred, DC ;
Mohsin, SK ;
Fuqua, SAW .
ENDOCRINE-RELATED CANCER, 2001, 8 (01) :47-61
[3]   Estrogen responsiveness and control of normal human breast proliferation [J].
Anderson, E ;
Clarke, RB ;
Howell, A .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1998, 3 (01) :23-35
[4]  
BARCELLOSHOFF MH, 2003, BREAST CANC RES S1, V5, P33
[5]   Cyclin D1 in breast cancer [J].
Barnes, DM ;
Gillett, CE .
BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) :1-15
[6]   Use of the autopsy to study ontogeny and expression of the estrogen receptor gene in human breast [J].
Bartow, SA .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1998, 3 (01) :37-48
[7]  
Beral Valerie, 2003, Lancet, V362, P419, DOI 10.1016/S0140-6736(03)14065-2
[8]   Mammary Gland Development and Tumorigenesis in Estrogen Receptor Knockout Mice [J].
Bocchinfuso, Wayne P. ;
Korach, Kenneth S. .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1997, 2 (04) :323-334
[9]   A paracrine role for the epithelial progesterone receptor in mammary gland development [J].
Brisken, C ;
Park, S ;
Vass, T ;
Lydon, JP ;
O'Malley, BW ;
Weinberg, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (09) :5076-5081
[10]  
Brisken C, 2000, GENE DEV, V14, P650